25 employees
Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions.
2011
$5.2M
from 3 investors over 3 rounds
Mitobridge, Inc. raised $5.2M on October 4, 2013
Investors: Longwood Fund and MPM Capital
Mitobridge, Inc. raised undisclosed on January 1, 2011
Investors: MPM Capital